547 related articles for article (PubMed ID: 29973242)
1. Identification and validation of single-sample breast cancer radiosensitivity gene expression predictors.
Sjöström M; Staaf J; Edén P; Wärnberg F; Bergh J; Malmström P; Fernö M; Niméus E; Fredriksson I
Breast Cancer Res; 2018 Jul; 20(1):64. PubMed ID: 29973242
[TBL] [Abstract][Full Text] [Related]
2. Breast carcinoma with 21-gene recurrence score lower than 18: rate of locoregional recurrence in a large series with clinical follow-up.
Turashvili G; Brogi E; Morrow M; Dickler M; Norton L; Hudis C; Wen HY
BMC Cancer; 2018 Jan; 18(1):42. PubMed ID: 29304773
[TBL] [Abstract][Full Text] [Related]
3. Integrating Radiosensitivity and Immune Gene Signatures for Predicting Benefit of Radiotherapy in Breast Cancer.
Cui Y; Li B; Pollom EL; Horst KC; Li R
Clin Cancer Res; 2018 Oct; 24(19):4754-4762. PubMed ID: 29921729
[No Abstract] [Full Text] [Related]
4. Development and Validation of a Novel Radiosensitivity Signature in Human Breast Cancer.
Speers C; Zhao S; Liu M; Bartelink H; Pierce LJ; Feng FY
Clin Cancer Res; 2015 Aug; 21(16):3667-77. PubMed ID: 25904749
[TBL] [Abstract][Full Text] [Related]
5. Integration of a Radiosensitivity Molecular Signature Into the Assessment of Local Recurrence Risk in Breast Cancer.
Torres-Roca JF; Fulp WJ; Caudell JJ; Servant N; Bollet MA; van de Vijver M; Naghavi AO; Harris EE; Eschrich SA
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):631-8. PubMed ID: 26461005
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling to predict the risk of locoregional recurrence in breast cancer: a pooled analysis.
Drukker CA; Elias SG; Nijenhuis MV; Wesseling J; Bartelink H; Elkhuizen P; Fowble B; Whitworth PW; Patel RR; de Snoo FA; van 't Veer LJ; Beitsch PD; Rutgers EJ
Breast Cancer Res Treat; 2014 Dec; 148(3):599-613. PubMed ID: 25414025
[TBL] [Abstract][Full Text] [Related]
7. A Signature That May Be Predictive of Early Versus Late Recurrence After Radiation Treatment for Breast Cancer That May Inform the Biology of Early, Aggressive Recurrences.
Speers C; Chang SL; Pesch A; Ritter C; Olsen E; Chandler B; Moubadder L; Liu M; Cameron M; Michmerhuizen A; Wilder-Romans K; Zhao SG; Nyati S; Bartelink H; Feng FY; Pierce LJ
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):686-696. PubMed ID: 32434041
[TBL] [Abstract][Full Text] [Related]
8. [Evidence-based radiotherapy in the treatment of early-stage invasive breast cancer: traditional clinical features and biomarkers].
Fodor J
Magy Onkol; 2009 Mar; 53(1):7-14. PubMed ID: 19318321
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling in primary breast cancer distinguishes patients developing local recurrence after breast-conservation surgery, with or without postoperative radiotherapy.
Niméus-Malmström E; Krogh M; Malmström P; Strand C; Fredriksson I; Karlsson P; Nordenskjöld B; Stål O; Ostberg G; Peterson C; Fernö M
Breast Cancer Res; 2008; 10(2):R34. PubMed ID: 18430221
[TBL] [Abstract][Full Text] [Related]
10. Development of triple-negative breast cancer radiosensitive gene signature and validation based on transcriptome analysis.
Wushou A; Jiang YZ; Hou J; Liu YR; Guo XM; Shao ZM
Breast Cancer Res Treat; 2015 Nov; 154(1):57-62. PubMed ID: 26476726
[TBL] [Abstract][Full Text] [Related]
11. Ipsilateral breast tumor recurrence (IBTR) in patients with operable breast cancer who undergo breast-conserving treatment after receiving neoadjuvant chemotherapy: risk factors of IBTR and validation of the MD Anderson Prognostic Index.
Ishitobi M; Ohsumi S; Inaji H; Ohno S; Shigematsu H; Akiyama F; Iwase T; Akashi-Tanaka S; Sato N; Takahashi K; Oura S
Cancer; 2012 Sep; 118(18):4385-93. PubMed ID: 22252882
[TBL] [Abstract][Full Text] [Related]
12. [Clinical characteristics and prognosis of patients with ipsilateral breast tumor recurrence after breast conservation therapy].
Sun GY; Wang SL; Tang Y; Jin J; Song YW; Liu YP; Wang WH; Fang H; Chen SY; Ren H; Liu XF; Yu ZH; Li YX
Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):352-358. PubMed ID: 29860762
[No Abstract] [Full Text] [Related]
13. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
[TBL] [Abstract][Full Text] [Related]
14. Interval between breast-conserving surgery and start of radiation therapy in early-stage breast cancer is not predictive of local recurrence: a single-institution experience.
Barbieri V; Sanpaolo P; Genovesi D
Clin Breast Cancer; 2011 Apr; 11(2):114-20. PubMed ID: 21569997
[TBL] [Abstract][Full Text] [Related]
15. Genomic predictor of residual risk of recurrence after adjuvant chemotherapy and endocrine therapy in high risk estrogen receptor-positive breast cancers.
Khan SS; Karn T; Symmans WF; Rody A; Müller V; Holtrich U; Becker S; Pusztai L; Hatzis C
Breast Cancer Res Treat; 2015 Feb; 149(3):789-97. PubMed ID: 25651779
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant Radiation Improves Survival in Older Women Following Breast-Conserving Surgery for Estrogen Receptor-Negative Breast Cancer.
Daugherty EC; Daugherty MR; Bogart JA; Shapiro A
Clin Breast Cancer; 2016 Dec; 16(6):500-506.e2. PubMed ID: 27431462
[TBL] [Abstract][Full Text] [Related]
17. 21-Gene Recurrence Score and Locoregional Recurrence in Node-Positive/ER-Positive Breast Cancer Treated With Chemo-Endocrine Therapy.
Mamounas EP; Liu Q; Paik S; Baehner FL; Tang G; Jeong JH; Kim SR; Butler SM; Jamshidian F; Cherbavaz DB; Sing AP; Shak S; Julian TB; Lembersky BC; Wickerham DL; Costantino JP; Wolmark N
J Natl Cancer Inst; 2017 Jan; 109(4):. PubMed ID: 28122895
[TBL] [Abstract][Full Text] [Related]
18. Expression of p53, glutathione S-transferase-pi, and Bcl-2 proteins and benefit from adjuvant radiotherapy in breast cancer.
Silvestrini R; Veneroni S; Benini E; Daidone MG; Luisi A; Leutner M; Maucione A; Kenda R; Zucali R; Veronesi U
J Natl Cancer Inst; 1997 May; 89(9):639-45. PubMed ID: 9150188
[TBL] [Abstract][Full Text] [Related]
19. Molecular signature of response to preoperative radiotherapy in locally advanced breast cancer.
Tanić M; Krivokuća A; Čavić M; Mladenović J; Plesinac Karapandžić V; Beck S; Radulović S; Susnjar S; Janković R
Radiat Oncol; 2018 Oct; 13(1):193. PubMed ID: 30285791
[TBL] [Abstract][Full Text] [Related]
20. Immune Infiltrate in the Primary Tumor Predicts Effect of Adjuvant Radiotherapy in Breast Cancer; Results from the Randomized SweBCG91RT Trial.
Stenmark Tullberg A; Puttonen HAJ; Sjöström M; Holmberg E; Chang SL; Feng FY; Speers C; Pierce LJ; Lundstedt D; Killander F; Niméus E; Kovács A; Karlsson P
Clin Cancer Res; 2021 Feb; 27(3):749-758. PubMed ID: 33148672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
